{"id":66082,"date":"2025-03-27T12:01:34","date_gmt":"2025-03-27T12:01:34","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/03\/27\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/"},"modified":"2025-03-27T12:01:34","modified_gmt":"2025-03-27T12:01:34","slug":"new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/","title":{"rendered":"New Data to Be Presented at Upcoming Congresses Showcase Cerevance&#8217;s Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders"},"content":{"rendered":"<div>\n<ul>\n<li style=\"text-align:left;\">Topline results from Phase 2 ASCEND trial of solengepras as a monotherapy treatment for early-stage Parkinson\u2019s to be presented<\/li>\n<li>First presentation of data from Phase 1 trial of novel KCNK13 inhibitor for CNS diseases targeting neuroinflammation<\/li>\n<li>Additional meeting presentations highlight potential of proprietary NETSseq platform to identify novel therapeutic targets for neurodegenerative diseases<\/li>\n<\/ul>\n<p>&#x200d;BOSTON, March  27, 2025  (GLOBE NEWSWIRE) &#8212; Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative, psychiatric, and central nervous system-controlled metabolic disorders, today announced upcoming presentations at the International Conference on Alzheimer\u2019s and Parkinson\u2019s Diseases and Related Neurological Disorders (AD\/PD&#x2122; 2025) being held April 1-5 in Vienna, and the American Academy of Neurology (AAN) Annual Meeting being held April 5-9 in San Diego.<\/p>\n<p><strong>Details of the oral presentation at <\/strong><strong>AD\/PD&#x2122; 2025 <\/strong><strong>are as follows:<\/strong><\/p>\n<p><strong>Title<\/strong>: Results of ASCEND: A Phase 2 Trial of Solengepras (CVN424) as an Investigational Monotherapy for Treatment of Early Parkinson\u2019s Disease<\/p>\n<ul type=\"disc\">\n<li>Presenter: Aaron L. Ellenbogen, DO, MPH<\/li>\n<li>Session Date\/Time: Tuesday, April 1, 2025, 1:15 p.m. CEST \/ 4:15 a.m. PT<\/li>\n<\/ul>\n<p><strong>Details of the poster presentations at the AAN 2025 Annual Meeting are as follows: <\/strong><\/p>\n<p><strong>Title:<\/strong> NETSseq Identifies Novel Therapeutic Targets for Neurodegenerative Diseases (#3592)<\/p>\n<ul type=\"disc\">\n<li>Presenter: Sagar Vaidya, M.D., Ph.D.<\/li>\n<li>Session Date\/Time: Sunday, April 6, 2025, 11:45 a.m. PT<\/li>\n<\/ul>\n<p><strong>Title:<\/strong> A First-in-Human Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN293, an Investigational Inhibitor of KCNK13 Targeting NLRP3-Mediated Neuroinflammation (#3282)<\/p>\n<ul type=\"disc\">\n<li>Presenter: Sagar Vaidya, M.D., Ph.D.<\/li>\n<li>Session Date\/Time: Tuesday, April 8, 2025, 8 a.m. PT<\/li>\n<\/ul>\n<p><strong>Title:<\/strong> Solengepras (CVN424): A Novel GPR6 Inhibitor in Clinical Development as an Investigational Therapy for Parkinson\u2019s Disease (#2892)<\/p>\n<ul type=\"disc\">\n<li>Presenter: Kelvin L. Chou, M.D., FAAN<\/li>\n<li>Session Date\/Time: Wednesday, April 9, 2025, 8 a.m. PT<\/li>\n<\/ul>\n<p><strong>About Cerevance<\/strong><\/p>\n<p>Cerevance is focused on advancing cell type-specific therapies for the treatment of neurodegenerative, psychiatric, and central nervous system-controlled metabolic disorders. Our proprietary platform, <strong>N<\/strong>uclear <strong>E<\/strong>nriched <strong>T<\/strong>ranscript <strong>S<\/strong>ort <strong>seq<\/strong>uencing (NETSseq), allows us to identify targets that are expressed at very low levels, that are present in rare cell types, or that change over time as a disease progresses. Our most advanced investigational treatment, solengepras, is currently in Phase 3 development and has the potential to be a first-in-class, oral non-dopaminergic therapy for both motor and non-motor symptoms of Parkinson&#8217;s disease. Our second investigational therapy, CVN766, is designed to be a highly selective oral antagonist of the orexin 1 receptor for the potential treatment of binge eating disorder and schizophrenia. Our third investigational treatment, CVN293, is a highly selective investigational oral inhibitor targeting potassium two pore domain channel subfamily K member 13 (KCNK13). CVN293 represents a potentially novel intervention point for neurodegenerative disorders and obesity. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oq1mfjeL5JxGosJExCTLII3MOXfGRdPyEt4hctzCaMHGvTx9Kw1rVH7fK0e3pqcagHlbtmpKpyEoB7k4ObpSIZuUY8hw6A_Yft7u4zjmFnU=\" rel=\"nofollow\" target=\"_blank\" title=\"www.cerevance.com\">www.cerevance.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8mOWMaw0NO6fG4mVJbiI-7YP0JkEA-TjLxGKsmF_WP11IX7uY4u1Z8WSpA3eEcHubdB1tRvS9oGVtMm9zNYPd7ry-3Wjz1d0_daHwLRM3vY=\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hwl4kBHiv6AhH7zRXpynjH_uIZe8gejTSXTjxncLgWynetclgWZAWDIMZknzWQytvIYjjHDzAnCvzwe33M2HDA==\" rel=\"nofollow\" target=\"_blank\" title=\"X\">X<\/a>.<\/p>\n<p align=\"left\"><strong>Contacts\u00a0<\/strong><br \/><strong>Cerevance:\u00a0<\/strong><br \/>Johnna Simoes, ir@cerevance.com<\/p>\n<p><strong>Media:<\/strong><br \/>April Dovorany, adovorany@realchemistry.com, +1-262-909-8739<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjRkMzZiNDEtYzI3MS00N2JlLTkxYWMtMTBlNTg4MmQ1MzU5LTEzMTAxMDctMjAyNS0wMy0yNy1lbg==\/tiny\/Cerevance-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Topline results from Phase 2 ASCEND trial of solengepras as a monotherapy treatment for early-stage Parkinson\u2019s to be presented First presentation of data from Phase 1 trial of novel KCNK13 inhibitor for CNS diseases targeting neuroinflammation Additional meeting presentations highlight potential of proprietary NETSseq platform to identify novel therapeutic targets for neurodegenerative diseases &#x200d;BOSTON, March [&#8230;]\n","protected":false},"author":1,"featured_media":66083,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-66082","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>New Data to Be Presented at Upcoming Congresses Showcase Cerevance&#039;s Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Data to Be Presented at Upcoming Congresses Showcase Cerevance&#039;s Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders\" \/>\n<meta property=\"og:description\" content=\"Topline results from Phase 2 ASCEND trial of solengepras as a monotherapy treatment for early-stage Parkinson\u2019s to be presented First presentation o\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-27T12:01:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/03\/Cerevance-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"New Data to Be Presented at Upcoming Congresses Showcase Cerevance&#8217;s Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders\",\"datePublished\":\"2025-03-27T12:01:34+00:00\",\"dateModified\":\"2025-03-27T12:01:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/\"},\"wordCount\":491,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/\",\"name\":\"New Data to Be Presented at Upcoming Congresses Showcase Cerevance's Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-03-27T12:01:34+00:00\",\"dateModified\":\"2025-03-27T12:01:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Data to Be Presented at Upcoming Congresses Showcase Cerevance&#8217;s Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"New Data to Be Presented at Upcoming Congresses Showcase Cerevance's Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/","og_locale":"en_US","og_type":"article","og_title":"New Data to Be Presented at Upcoming Congresses Showcase Cerevance's Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders","og_description":"Topline results from Phase 2 ASCEND trial of solengepras as a monotherapy treatment for early-stage Parkinson\u2019s to be presented First presentation o","og_url":"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-03-27T12:01:34+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/03\/Cerevance-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"New Data to Be Presented at Upcoming Congresses Showcase Cerevance&#8217;s Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders","datePublished":"2025-03-27T12:01:34+00:00","dateModified":"2025-03-27T12:01:34+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/"},"wordCount":491,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/","url":"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/","name":"New Data to Be Presented at Upcoming Congresses Showcase Cerevance's Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-03-27T12:01:34+00:00","dateModified":"2025-03-27T12:01:34+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/new-data-to-be-presented-at-upcoming-congresses-showcase-cerevances-advanced-clinical-program-in-parkinsons-disease-and-deep-pipeline-for-cns-based-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"New Data to Be Presented at Upcoming Congresses Showcase Cerevance&#8217;s Advanced Clinical Program in Parkinson\u2019s Disease and Deep Pipeline for CNS-based Disorders"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/66082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=66082"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/66082\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/66083"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=66082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=66082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=66082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}